These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 26342176)
1. Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway. Deng J; Habib A; Obregon DF; Barger SW; Giunta B; Wang YJ; Hou H; Sawmiller D; Tan J J Neurochem; 2015 Nov; 135(3):630-7. PubMed ID: 26342176 [TBL] [Abstract][Full Text] [Related]
2. Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer's disease. Zhu Y; Wang J Neurol Sci; 2015 Jul; 36(7):1181-8. PubMed ID: 25596147 [TBL] [Abstract][Full Text] [Related]
3. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation. Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757 [TBL] [Abstract][Full Text] [Related]
4. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105 [TBL] [Abstract][Full Text] [Related]
5. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study. Zhang ZX; Zhao RP; Wang DS; Wang AN Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. Rockenstein E; Torrance M; Adame A; Mante M; Bar-on P; Rose JB; Crews L; Masliah E J Neurosci; 2007 Feb; 27(8):1981-91. PubMed ID: 17314294 [TBL] [Abstract][Full Text] [Related]
7. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways. Hu JP; Xie JW; Wang CY; Wang T; Wang X; Wang SL; Teng WP; Wang ZY Brain Res Bull; 2011 May; 85(3-4):194-200. PubMed ID: 21435383 [TBL] [Abstract][Full Text] [Related]
8. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice. Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430 [TBL] [Abstract][Full Text] [Related]
9. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736 [TBL] [Abstract][Full Text] [Related]
10. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814 [TBL] [Abstract][Full Text] [Related]
11. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex. Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051 [TBL] [Abstract][Full Text] [Related]
12. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators. Maurya SK; Mishra J; Abbas S; Bandyopadhyay S Mol Neurobiol; 2016 Mar; 53(2):968-982. PubMed ID: 25575682 [TBL] [Abstract][Full Text] [Related]
13. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. Stein TD; Anders NJ; DeCarli C; Chan SL; Mattson MP; Johnson JA J Neurosci; 2004 Sep; 24(35):7707-17. PubMed ID: 15342738 [TBL] [Abstract][Full Text] [Related]
14. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice. Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570 [TBL] [Abstract][Full Text] [Related]
15. GRK5 influences the phosphorylation of tau via GSK3β and contributes to Alzheimer's disease. Zhao J; Li X; Chen X; Cai Y; Wang Y; Sun W; Mai H; Yang J; Fan W; Tang P; Ou M; Zhang Y; Huang X; Zhao B; Cui L J Cell Physiol; 2019 Jul; 234(7):10411-10420. PubMed ID: 30511419 [TBL] [Abstract][Full Text] [Related]
16. The Streptomyces metabolite anhydroexfoliamycin ameliorates hallmarks of Alzheimer's disease in vitro and in vivo. Leirós M; Alonso E; Rateb ME; Ebel R; Jaspars M; Alfonso A; Botana LM Neuroscience; 2015 Oct; 305():26-35. PubMed ID: 26247694 [TBL] [Abstract][Full Text] [Related]
17. Human Umbilical Cord Blood Serum-derived α-Secretase: Functional Testing in Alzheimer's Disease Mouse Models. Habib A; Hou H; Mori T; Tian J; Zeng J; Fan S; Giunta B; Sanberg PR; Sawmiller D; Tan J Cell Transplant; 2018 Mar; 27(3):438-455. PubMed ID: 29560732 [TBL] [Abstract][Full Text] [Related]
18. C-Reactive Protein Induces Tau Hyperphosphorylation via GSK3β Signaling Pathway in SH-SY5Y Cells. Guo H; Wang H; Wang C; Cheng Y; Zou Z; Li Y; Wu J; Xu J J Mol Neurosci; 2015 Jun; 56(2):519-27. PubMed ID: 25966642 [TBL] [Abstract][Full Text] [Related]
19. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase. Mudher A; Chapman S; Richardson J; Asuni A; Gibb G; Pollard C; Killick R; Iqbal T; Raymond L; Varndell I; Sheppard P; Makoff A; Gower E; Soden PE; Lewis P; Murphy M; Golde TE; Rupniak HT; Anderton BH; Lovestone S J Neurosci; 2001 Jul; 21(14):4987-95. PubMed ID: 11438574 [TBL] [Abstract][Full Text] [Related]
20. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]